Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
1.
Age (Dordr) ; 38(5-6): 379-391, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27590905

ABSTRACT

Statins, such as simvastatin, and ACE inhibitors (ACEis), such as ramipril, are standard therapies for the prevention and treatment of cardiovascular diseases. These types of drugs are commonly administered together. More recently, angiotensin II type 1 receptor (AT1R) antagonists, such as candesartan cilexetil (candesartan), have been used in the place of, or in combination with, ACEis. Here, we investigated the effects of simvastatin and ramipril single and combination therapy, and candesartan treatment on the lifespan of isocalorically fed, long-lived, B6C3F1 mice. Males were used for their relative endocrine simplicity and to minimize animal usage. The drugs were administered daily in food. The simvastatin and ramipril combination therapy significantly increased the mean and median lifespan by 9 %. In contrast, simvastatin, ramipril, or candesartan monotherapy was ineffective. All groups consumed the same number of calories. Simvastatin, alone or administered with ramipril, decreased body weight without changing caloric consumption, suggesting it may alter energy utilization in mice. Combination therapy elevated serum triglyceride and glucose levels, consistent with altered energy homeostasis. Few significant or consistent differences were found in mortality-associated pathologies among the groups. Simvastatin treatment did not reduce normal serum cholesterol or lipid levels in these mice, suggesting that the longevity effects may stem from the pleiotropic, non-cholesterol-related, effects of statins. Together, the results suggest that statins and ACEis together may enhance mouse longevity. Statins and ACE inhibitors are generally well-tolerated, and in combination, they have been shown to increase the lifespan of normotensive, normocholesterolemic humans.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/pharmacology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Longevity/drug effects , Ramipril/pharmacology , Simvastatin/pharmacology , Angiotensin-Converting Enzyme Inhibitors/administration & dosage , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Animals , Antihypertensive Agents/administration & dosage , Antihypertensive Agents/pharmacology , Antihypertensive Agents/therapeutic use , Benzimidazoles/administration & dosage , Benzimidazoles/pharmacology , Benzimidazoles/therapeutic use , Biphenyl Compounds , Blood Glucose/analysis , Cholesterol/blood , Chromatography, Liquid , Cohort Studies , Drug Synergism , Drug Therapy, Combination , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Kaplan-Meier Estimate , Male , Mice , Mice, Inbred C57BL , Ramipril/administration & dosage , Ramipril/therapeutic use , Simvastatin/administration & dosage , Simvastatin/therapeutic use , Tandem Mass Spectrometry , Tetrazoles/administration & dosage , Tetrazoles/pharmacology , Tetrazoles/therapeutic use , Triglycerides/blood
2.
Genomics Insights ; 9: 29-39, 2016.
Article in English | MEDLINE | ID: mdl-27042094

ABSTRACT

In mammals, extracellular miRNAs circulate in biofluids as stable entities that are secreted by normal and diseased tissues, and can enter cells and regulate gene expression. Drosophila melanogaster is a proven system for the study of human diseases. They have an open circulatory system in which hemolymph (HL) circulates in direct contact with all internal organs, in a manner analogous to vertebrate blood plasma. Here, we show using deep sequencing that Drosophila HL contains RNase-resistant circulating miRNAs (HL-miRNAs). Limited subsets of body tissue miRNAs (BT-miRNAs) accumulated in HL, suggesting that they may be specifically released from cells or particularly stable in HL. Alternatively, they might arise from specific cells, such as hemocytes, that are in intimate contact with HL. Young and old flies accumulated unique populations of HL-miRNAs, suggesting that their accumulation is responsive to the physiological status of the fly. These HL-miRNAs in flies may function similar to the miRNAs circulating in mammalian biofluids. The discovery of these HL-miRNAs will provide a new venue for health and disease-related research in Drosophila.

3.
Mol Cell Biol ; 35(20): 3471-90, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26240283

ABSTRACT

The nuclear receptor hepatocyte nuclear factor 4α (HNF4α) is tumor suppressive in the liver but amplified in colon cancer, suggesting that it also might be oncogenic. To investigate whether this discrepancy is due to different HNF4α isoforms derived from its two promoters (P1 and P2), we generated Tet-On-inducible human colon cancer (HCT116) cell lines that express either the P1-driven (HNF4α2) or P2-driven (HNF4α8) isoform and analyzed them for tumor growth and global changes in gene expression (transcriptome sequencing [RNA-seq] and chromatin immunoprecipitation sequencing [ChIP-seq]). The results show that while HNF4α2 acts as a tumor suppressor in the HCT116 tumor xenograft model, HNF4α8 does not. Each isoform regulates the expression of distinct sets of genes and recruits, colocalizes, and competes in a distinct fashion with the Wnt/ß-catenin mediator T-cell factor 4 (TCF4) at CTTTG motifs as well as at AP-1 motifs (TGAXTCA). Protein binding microarrays (PBMs) show that HNF4α and TCF4 share some but not all binding motifs and that single nucleotide polymorphisms (SNPs) in sites bound by both HNF4α and TCF4 can alter binding affinity in vitro, suggesting that they could play a role in cancer susceptibility in vivo. Thus, the HNF4α isoforms play distinct roles in colon cancer, which could be due to differential interactions with the Wnt/ß-catenin/TCF4 and AP-1 pathways.


Subject(s)
Colorectal Neoplasms/metabolism , Hepatocyte Nuclear Factor 1-alpha/metabolism , Hepatocyte Nuclear Factor 4/physiology , Transcription Factor AP-1/metabolism , Animals , Base Sequence , Binding, Competitive , Colorectal Neoplasms/genetics , Colorectal Neoplasms/pathology , Consensus Sequence , Gene Expression Regulation, Neoplastic , Gene Ontology , HCT116 Cells , Humans , Male , Mice, Nude , Neoplasm Transplantation , Polymorphism, Single Nucleotide , Protein Binding , Protein Isoforms/physiology , Transcriptome , Tumor Burden
4.
Aging Cell ; 14(6): 1055-66, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26176567

ABSTRACT

Recent evidence demonstrates that serum levels of specific miRNAs significantly change with age. The ability of circulating sncRNAs to act as signaling molecules and regulate a broad spectrum of cellular functions implicates them as key players in the aging process. To discover circulating sncRNAs that impact aging in the long-lived Ames dwarf mice, we conducted deep sequencing of small RNAs extracted from serum of young and old mice. Our analysis showed genotype-specific changes in the circulating levels of 21 miRNAs during aging [genotype-by-age interaction (GbA)]. Genotype-by-age miRNAs showed four distinct expression patterns and significant overtargeting of transcripts involved in age-related processes. Functional enrichment analysis of putative and validated miRNA targets highlighted cellular processes such as tumor suppression, anti-inflammatory response, and modulation of Wnt, insulin, mTOR, and MAPK signaling pathways, among others. The comparative analysis of circulating GbA miRNAs in Ames mice with circulating miRNAs modulated by calorie restriction (CR) in another long-lived mouse suggests CR-like and CR-independent mechanisms contributing to longevity in the Ames mouse. In conclusion, we showed for the first time a signature of circulating miRNAs modulated by age in the long-lived Ames mouse.


Subject(s)
Aging/genetics , Dwarfism, Pituitary/genetics , Longevity/genetics , MicroRNAs/blood , Animals , Base Sequence , Caloric Restriction , Female , Genotype , High-Throughput Nucleotide Sequencing , Insulin/metabolism , MAP Kinase Signaling System/genetics , Male , Mice , Mice, Knockout , MicroRNAs/genetics , Sequence Analysis, DNA , TOR Serine-Threonine Kinases/metabolism , Wnt Proteins/metabolism
5.
Oncotarget ; 6(22): 19246-63, 2015 Aug 07.
Article in English | MEDLINE | ID: mdl-26057471

ABSTRACT

The Head and Neck Squamous Cell Carcinoma (HNSCC) is the sixth most common human cancer, causing 350,000 individuals die worldwide each year. The overall prognosis in HNSCC patients has not significantly changed for the last decade. Complete understanding of the molecular mechanisms in HNSCC carcinogenesis could allow an earlier diagnosis and the use of more specific and effective therapies. In the present study we used deep sequencing to characterize small non-coding RNAs (sncRNAs) in serum from HNSCC patients and healthy donors. We identified, for the first time, a multi-marker signature of 3 major classes of circulating sncRNAs in HNSCC, revealing the presence of circulating novel and known miRNAs, and tRNA- and YRNA-derived small RNAs that were significantly deregulated in the sera of HNSCC patients compared to healthy controls. By implementing a triple-filtering approach we identified a subset of highly biologically relevant miRNA-mRNA interactions and we demonstrated that the same genes/pathways affected by somatic mutations in cancer are affected by changes in the abundance of miRNAs. Therefore, one important conclusion from our work is that during cancer development, there seems to be a convergence of oncogenic processes driven by somatic mutations and/or miRNA regulation affecting key cellular pathways.


Subject(s)
Biomarkers, Tumor/blood , Carcinoma, Squamous Cell/genetics , Head and Neck Neoplasms/genetics , MicroRNAs/blood , RNA, Untranslated/blood , Aged , Biomarkers, Tumor/genetics , Carcinoma, Squamous Cell/blood , Carcinoma, Squamous Cell/pathology , Female , Head and Neck Neoplasms/blood , Head and Neck Neoplasms/pathology , Humans , Male , MicroRNAs/genetics , Middle Aged , Mouth Neoplasms/blood , Mouth Neoplasms/genetics , Mouth Neoplasms/pathology , Neoplasm Staging , Prognosis , RNA, Untranslated/genetics , Squamous Cell Carcinoma of Head and Neck
6.
Aging Cell ; 14(4): 497-510, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25902704

ABSTRACT

The workshop entitled 'Interventions to Slow Aging in Humans: Are We Ready?' was held in Erice, Italy, on October 8-13, 2013, to bring together leading experts in the biology and genetics of aging and obtain a consensus related to the discovery and development of safe interventions to slow aging and increase healthy lifespan in humans. There was consensus that there is sufficient evidence that aging interventions will delay and prevent disease onset for many chronic conditions of adult and old age. Essential pathways have been identified, and behavioral, dietary, and pharmacologic approaches have emerged. Although many gene targets and drugs were discussed and there was not complete consensus about all interventions, the participants selected a subset of the most promising strategies that could be tested in humans for their effects on healthspan. These were: (i) dietary interventions mimicking chronic dietary restriction (periodic fasting mimicking diets, protein restriction, etc.); (ii) drugs that inhibit the growth hormone/IGF-I axis; (iii) drugs that inhibit the mTOR-S6K pathway; or (iv) drugs that activate AMPK or specific sirtuins. These choices were based in part on consistent evidence for the pro-longevity effects and ability of these interventions to prevent or delay multiple age-related diseases and improve healthspan in simple model organisms and rodents and their potential to be safe and effective in extending human healthspan. The authors of this manuscript were speakers and discussants invited to the workshop. The following summary highlights the major points addressed and the conclusions of the meeting.


Subject(s)
Aging/drug effects , Biological Factors/therapeutic use , Longevity/drug effects , Prescription Drugs/therapeutic use , AMP-Activated Protein Kinases/genetics , AMP-Activated Protein Kinases/metabolism , Aging/genetics , Animals , Caloric Restriction/methods , Diet , Enzyme Activation , Gene Expression Regulation , Growth Hormone/antagonists & inhibitors , Growth Hormone/genetics , Growth Hormone/metabolism , Humans , Insulin-Like Growth Factor I/antagonists & inhibitors , Insulin-Like Growth Factor I/genetics , Insulin-Like Growth Factor I/metabolism , Longevity/genetics , Mice , Ribosomal Protein S6 Kinases/antagonists & inhibitors , Ribosomal Protein S6 Kinases/genetics , Ribosomal Protein S6 Kinases/metabolism , Signal Transduction , Sirtuins/genetics , Sirtuins/metabolism , TOR Serine-Threonine Kinases/antagonists & inhibitors , TOR Serine-Threonine Kinases/genetics , TOR Serine-Threonine Kinases/metabolism
7.
J Gerontol A Biol Sci Med Sci ; 70(12): 1479-89, 2015 Dec.
Article in English | MEDLINE | ID: mdl-25380600

ABSTRACT

Mesonordihydroguaiaretic acid (NDGA) extends murine lifespan. The studies reported here describe its dose dependence, effects on body weight, toxicity-related clinical chemistries, and mortality-related pathologies. In flies, we characterized its effects on lifespan, food consumption, body weight, and locomotion. B6C3F1 mice were fed AIN-93M diet supplemented with 1.5, 2.5, 3.5, or 4.5 g NDGA/kg diet (1.59, 2.65, 3.71 and 4.77 mg/kg body weight/day) beginning at 12 months of age. Only the 3.5 mg/kg diet produced a highly significant increase in lifespan, as judged by either the Mantel-Cox log-rank test (p = .008) or the Gehan-Breslow-Wilcoxon test (p = .009). NDGA did not alter food intake, but dose-responsively reduced weight, suggesting it decreased the absorption or increased the utilization of calories. NDGA significantly increased the incidence of liver, lung, and thymus tumors, and peritoneal hemorrhagic diathesis found at necropsy. However, clinical chemistries found little evidence for overt toxicity. While NDGA was not overtly toxic at its therapeutic dosage, its association with severe end of life pathologies does not support the idea that NDGA consumption will increase human lifespan or health-span. The less toxic derivatives of NDGA which are under development should be explored as anti-aging therapeutics.


Subject(s)
Antioxidants/pharmacology , Drosophila/physiology , Energy Metabolism/drug effects , Hemorrhagic Disorders/chemically induced , Homeostasis/drug effects , Longevity/drug effects , Masoprocol/pharmacology , Mice/physiology , Neoplasms/chemically induced , Neoplasms/mortality , Animals , Body Weight/drug effects , Dose-Response Relationship, Drug , Eating/drug effects , Male
8.
Biomark Cancer ; 6: 37-47, 2014.
Article in English | MEDLINE | ID: mdl-25520563

ABSTRACT

Small noncoding RNAs circulating in the blood may serve as signaling molecules because of their ability to carry out a variety of cellular functions. We have previously described tRNA- and YRNA-derived small RNAs circulating as components of larger complexes in the blood of humans and mice; the characteristics of these small RNAs imply specific processing, secretion, and physiological regulation. In this study, we have asked if changes in the serum abundance of these tRNA and YRNA fragments are associated with a diagnosis of cancer. We used deep sequencing and informatics analysis to catalog small RNAs in the sera of breast cancer cases and normal controls. 5' tRNA halves and YRNA fragments are abundant in both groups, but we found that a breast cancer diagnosis is associated with changes in levels of specific subtypes. This prompted us to look at existing sequence datasets of serum small RNAs from 42 breast cancer cases, taken at the time of diagnosis. We find significant changes in the levels of specific 5' tRNA halves and YRNA fragments associated with clinicopathologic characteristics of the cancer. Although these findings do not establish causality, they suggest that circulating 5' tRNA halves and YRNA fragments with known cellular functions may participate in breast cancer syndromes and have potential as circulating biomarkers. Larger studies with multiple types of cancer are needed to adequately evaluate their potential use for the development of noninvasive cancer screening.

9.
Age (Dordr) ; 36(3): 9659, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24816553

ABSTRACT

Marine oils rich in ω-3 polyunsaturated fatty acids have been recommended as a preventive treatment for patients at risk for cardiovascular diseases. These oils also are the third most consumed dietary supplement in the USA. However, evidence for their health benefits is equivocal. We tested the daily, isocaloric administration of krill oil (1.17 g oil/kg diet) and Lovaza (Omacor; 4.40 g/kg diet), a pharmaceutical grade fish oil, beginning at 12 months of age, on the life span and mortality-related pathologies of long-lived, male, B6C3F1 mice. The oils were incorporated into the chemically defined American Institute of Nutrition (AIN)-93 M diet. An equivalent volume of soybean oil was removed. Krill oil was 3 % and Lovaza 11 % of the oil in the diets. When their effects were analyzed together, the marine oils significantly shortened life span by 6.6 % (P = 0.0321; log-rank test) relative to controls. Individually, Lovaza and krill oil non-significantly shortened median life span by 9.8 and 4.7 %, respectively. Lovaza increased the number of enlarged seminal vesicles (7.1-fold). Lovaza and krill oil significantly increased lung tumors (4.1- and 8.2-fold) and hemorrhagic diathesis (3.9- and 3.1-fold). Analysis of serum from treated mice found that Lovaza slightly increased blood urea nitrogen, while krill oil modestly increased bilirubin, triglycerides, and blood glucose levels. Taken together, the results do not support the idea that the consumption of isolated ω-3 fatty acid-rich oils will increase the life span or health of initially healthy individuals.


Subject(s)
Aging/drug effects , Dietary Proteins/pharmacology , Dietary Supplements , Docosahexaenoic Acids , Eicosapentaenoic Acid , Fatty Acids, Omega-3 , Longevity/drug effects , Animals , Crustacea , Drug Combinations , Longevity/physiology , Male , Mice
10.
Mol Cell ; 53(1): 63-74, 2014 Jan 09.
Article in English | MEDLINE | ID: mdl-24289924

ABSTRACT

While p53 activation has long been studied, the mechanisms by which its targets genes are restored to their preactivation state are less clear. We report here that TAF1 phosphorylates p53 at Thr55, leading to dissociation of p53 from the p21 promoter and inactivation of transcription late in the DNA damage response. We further show that cellular ATP level might act as a molecular switch for Thr55 phosphorylation on the p21 promoter, indicating that TAF1 is a cellular ATP sensor. Upon DNA damage, cells undergo PARP-1-dependent ATP depletion, which is correlated with reduced TAF1 kinase activity and Thr55 phosphorylation, resulting in p21 activation. As cellular ATP levels recover, TAF1 is able to phosphorylate p53 on Thr55, which leads to dissociation of p53 from the p21 promoter. ChIP-sequencing analysis reveals p53 dissociates from promoters genome wide as cells recover from DNA damage, suggesting the general nature of this mechanism.


Subject(s)
DNA Damage , Histone Acetyltransferases/metabolism , Promoter Regions, Genetic , TATA-Binding Protein Associated Factors/metabolism , Transcription Factor TFIID/metabolism , Transcription, Genetic , Tumor Suppressor Protein p53/metabolism , Adenosine Triphosphate/genetics , Adenosine Triphosphate/metabolism , Cell Line , Cyclin-Dependent Kinase Inhibitor p21/genetics , Cyclin-Dependent Kinase Inhibitor p21/metabolism , Genome-Wide Association Study , Histone Acetyltransferases/genetics , Humans , Phosphorylation/genetics , TATA-Binding Protein Associated Factors/genetics , Transcription Factor TFIID/genetics , Tumor Suppressor Protein p53/genetics
11.
Age (Dordr) ; 36(2): 705-18, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24370781

ABSTRACT

Present data suggest that the consumption of individual dietary supplements does not enhance the health or longevity of healthy rodents or humans. It might be argued that more complex combinations of such agents might extend lifespan or health-span by more closely mimicking the complexity of micronutrients in fruits and vegetables, which appear to extend health-span and longevity. To test this hypothesis we treated long-lived, male, F1 mice with published and commercial combinations of dietary supplements and natural product extracts, and determined their effects on lifespan and health-span. Nutraceutical, vitamin or mineral combinations reported to extend the lifespan or health-span of healthy or enfeebled rodents were tested, as were combinations of botanicals and nutraceuticals implicated in enhanced longevity by a longitudinal study of human aging. A cross-section of commercial nutraceutical combinations sold as potential health enhancers also were tested, including Bone Restore®, Juvenon®, Life Extension Mix®, Ortho Core®, Ortho Mind®, Super K w k2®, and Ultra K2®. A more complex mixture of vitamins, minerals, botanical extracts and other nutraceuticals was compounded and tested. No significant increase in murine lifespan was found for any supplement mixture. Our diverse supplement mixture significantly decreased lifespan. Thus, our results do not support the hypothesis that simple or complex combinations of nutraceuticals, including antioxidants, are effective in delaying the onset or progress of the major causes of death in mice. The results are consistent with epidemiological studies suggesting that dietary supplements are not beneficial and even may be harmful for otherwise healthy individuals.


Subject(s)
Aging/drug effects , Dietary Supplements , Longevity/drug effects , Animal Feed , Animals , Life Expectancy , Male , Mice
12.
Physiol Genomics ; 45(21): 990-8, 2013 Nov 01.
Article in English | MEDLINE | ID: mdl-24022222

ABSTRACT

Small noncoding RNAs carry out a variety of functions in eukaryotic cells, and in multiple species they can travel between cells, thus serving as signaling molecules. In mammals multiple small RNAs have been found to circulate in the blood, although in most cases the targets of these RNAs, and even their functions, are not well understood. YRNAs are small (84-112 nt) RNAs with poorly characterized functions, best known because they make up part of the Ro ribonucleoprotein autoantigens in connective tissue diseases. In surveying small RNAs present in the serum of healthy adult humans, we have found YRNA fragments of lengths 27 nt and 30-33 nt, derived from the 5'-ends of specific YRNAs and generated by cleavage within a predicted internal loop. Many of the YRNAs from which these fragments are derived were previously annotated only as pseudogenes, or predicted informatically. These 5'-YRNA fragments make up a large proportion of all small RNAs (including miRNAs) present in human serum. They are also present in plasma, are not present in exosomes or microvesicles, and circulate as part of a complex with a mass between 100 and 300 kDa. Mouse serum contains far fewer 5'-YRNA fragments, possibly reflecting the much greater copy number of YRNA genes and pseudogenes in humans. The function of the 5'-YRNA fragments is at present unknown, but the processing and secretion of specific YRNAs to produce 5'-end fragments that circulate in stable complexes are consistent with a signaling function.


Subject(s)
Pseudogenes/genetics , RNA Processing, Post-Transcriptional , RNA, Small Untranslated/genetics , RNA/genetics , Adult , Animals , Base Sequence , Blotting, Northern , DNA, Complementary/chemistry , DNA, Complementary/genetics , Humans , Male , Mice , Molecular Sequence Data , Nucleic Acid Conformation , RNA, Small Untranslated/blood , RNA, Small Untranslated/chemistry , Ribonucleoproteins/genetics , Sequence Analysis, DNA
13.
Nat Commun ; 4: 2192, 2013.
Article in English | MEDLINE | ID: mdl-23900241

ABSTRACT

Metformin is a drug commonly prescribed to treat patients with type 2 diabetes. Here we show that long-term treatment with metformin (0.1% w/w in diet) starting at middle age extends healthspan and lifespan in male mice, while a higher dose (1% w/w) was toxic. Treatment with metformin mimics some of the benefits of calorie restriction, such as improved physical performance, increased insulin sensitivity, and reduced low-density lipoprotein and cholesterol levels without a decrease in caloric intake. At a molecular level, metformin increases AMP-activated protein kinase activity and increases antioxidant protection, resulting in reductions in both oxidative damage accumulation and chronic inflammation. Our results indicate that these actions may contribute to the beneficial effects of metformin on healthspan and lifespan. These findings are in agreement with current epidemiological data and raise the possibility of metformin-based interventions to promote healthy aging.


Subject(s)
Health , Longevity/drug effects , Metformin/pharmacology , AMP-Activated Protein Kinases , Animals , Antioxidants/pharmacology , Biomarkers/blood , Caloric Restriction , Electron Transport/drug effects , Enzyme Activation/drug effects , Inflammation/blood , Inflammation/drug therapy , Inflammation/pathology , Male , Metformin/therapeutic use , Mice , Mice, Inbred C57BL , Mitochondria/drug effects , Mitochondria/metabolism , Survival Analysis , Transcriptome/drug effects , Transcriptome/genetics
14.
BMC Genomics ; 14: 298, 2013 May 02.
Article in English | MEDLINE | ID: mdl-23638709

ABSTRACT

BACKGROUND: Small RNAs complex with proteins to mediate a variety of functions in animals and plants. Some small RNAs, particularly miRNAs, circulate in mammalian blood and may carry out a signaling function by entering target cells and modulating gene expression. The subject of this study is a set of circulating 30-33 nt RNAs that are processed derivatives of the 5' ends of a small subset of tRNA genes, and closely resemble cellular tRNA derivatives (tRFs, tiRNAs, half-tRNAs, 5' tRNA halves) previously shown to inhibit translation initiation in response to stress in cultured cells. RESULTS: In sequencing small RNAs extracted from mouse serum, we identified abundant 5' tRNA halves derived from a small subset of tRNAs, implying that they are produced by tRNA type-specific biogenesis and/or release. The 5' tRNA halves are not in exosomes or microvesicles, but circulate as particles of 100-300 kDa. The size of these particles suggest that the 5' tRNA halves are a component of a macromolecular complex; this is supported by the loss of 5' tRNA halves from serum or plasma treated with EDTA, a chelating agent, but their retention in plasma anticoagulated with heparin or citrate. A survey of somatic tissues reveals that 5' tRNA halves are concentrated within blood cells and hematopoietic tissues, but scant in other tissues, suggesting that they may be produced by blood cells. Serum levels of specific subtypes of 5' tRNA halves change markedly with age, either up or down, and these changes can be prevented by calorie restriction. CONCLUSIONS: We demonstrate that 5' tRNA halves circulate in the blood in a stable form, most likely as part of a nucleoprotein complex, and their serum levels are subject to regulation by age and calorie restriction. They may be produced by blood cells, but their cellular targets are not yet known. The characteristics of these circulating molecules, and their known function in suppression of translation initiation, suggest that they are a novel form of signaling molecule.


Subject(s)
Aging/genetics , Blood Cells/metabolism , Caloric Restriction , RNA, Transfer/blood , RNA, Transfer/genetics , Animals , Edetic Acid/pharmacology , Male , Mice , MicroRNAs/genetics , MicroRNAs/metabolism , Nucleoproteins/blood , Peptide Chain Initiation, Translational/drug effects , RNA, Transfer/drug effects , Tissue Distribution
15.
Aging (Albany NY) ; 5(2): 130-41, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23470454

ABSTRACT

MicroRNAs (miRNAs) function to modulate gene expression, and through this property they regulate a broad spectrum of cellular processes. They can circulate in blood and thereby mediate cell-to-cell communication. Aging involves changes in many cellular processes that are potentially regulated by miRNAs, and some evidence has implicated circulating miRNAs in the aging process. In order to initiate a comprehensive assessment of the role of circulating miRNAs in aging, we have used deep sequencing to characterize circulating miRNAs in the serum of young mice, old mice, and old mice maintained on calorie restriction (CR). Deep sequencing identifies a set of novel miRNAs, and also accurately measures all known miRNAs present in serum. This analysis demonstrates that the levels of many miRNAs circulating in the mouse are increased with age, and that the increases can be antagonized by CR. The genes targeted by this set of age-modulated miRNAs are predicted to regulate biological processes directly relevant to the manifestations of aging including metabolic changes, and the miRNAs themselves have been linked to diseases associated with old age. This finding implicates circulating miRNAs in the aging process, raising questions about their tissues of origin, their cellular targets, and their functional role in metabolic changes that occur with aging.


Subject(s)
Aging/genetics , Caloric Restriction/methods , High-Throughput Nucleotide Sequencing/methods , MicroRNAs/genetics , Aging/metabolism , Animals , Mice , MicroRNAs/blood , MicroRNAs/metabolism
16.
Rejuvenation Res ; 16(2): 143-51, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23432089

ABSTRACT

Phytonutrients reportedly extend the life span of Caenorhabditis elegans, Drosophila, and mice. We tested extracts of blueberry, pomegranate, green and black tea, cinnamon, sesame, and French maritime pine bark (Pycnogenol and taxifolin), as well as curcumin, morin, and quercetin for their effects on the life span of mice. While many of these phytonutrients reportedly extend the life span of model organisms, we found no significant effect on the life span of male F1 hybrid mice, even though the dosages used reportedly produce defined therapeutic end points in mice. The compounds were fed beginning at 12 months of age. The control and treatment groups were iso-caloric with respect to one another. A 40% calorically restricted and other groups not reported here did experience life span extension. Body weights were un-changed relative to controls for all but two supplemented groups, indicating most supplements did not change energy absorption or utilization. Tea extracts with morin decreased weight, whereas quercetin, taxifolin, and Pycnogenol together increased weight. These changes may be due to altered locomotion or fatty acid biosynthesis. Published reports of murine life span extension using curcumin or tea components may have resulted from induced caloric restriction. Together, our results do not support the idea that isolated phytonutrient anti-oxidants and anti-inflammatories are potential longevity therapeutics, even though consumption of whole fruits and vegetables is associated with enhanced health span and life span.


Subject(s)
Blueberry Plants/chemistry , Cinnamomum zeylanicum/chemistry , Flavonols/pharmacology , Longevity/physiology , Lythraceae/chemistry , Sesamum/chemistry , Tea/chemistry , Animals , Body Weight/drug effects , Crosses, Genetic , Curcumin/pharmacology , Feeding Behavior/drug effects , Female , Flavonoids/pharmacology , Hybridization, Genetic/drug effects , Longevity/drug effects , Male , Mice , Mice, Inbred C57BL , Plant Extracts , Quercetin/analogs & derivatives , Quercetin/pharmacology
17.
Age (Dordr) ; 35(6): 2099-109, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23314750

ABSTRACT

Chronic treatment with ß-adrenergic receptor (ßAR) agonists increases mortality and morbidity while ßAR antagonists (ß-blockers) decrease all-cause mortality for those at risk of cardiac disease. Levels of sympathetic nervous system ßAR agonists and ßAR activity increase with age, and this increase may hasten the development of age-related mortality. Here, we show that ß-blockers extend the life span of healthy metazoans. The ß-blockers metoprolol and nebivolol, administered in food daily beginning at 12 months of age, significantly increase the mean and median life span of isocalorically fed, male C3B6F1 mice, by 10 and 6.4%, respectively (P < 0.05). Neither drug affected the weight or food intake of the mice, indicating that induced CR is not responsible for these effects, and that energy absorption and utilization are not altered by the drugs. Both ß-blockers were investigated to control for their idiosyncratic, off-target effects. Metoprolol and nebivolol extended Drosophila life span, without affecting food intake or locomotion. Thus, ßAR antagonists are capable of directly extending the life span of two widely divergent metazoans, suggesting that these effects are phylogenetically highly conserved. Thus, long-term use of ß-blockers, which are generally well-tolerated, may enhance the longevity of healthy humans.


Subject(s)
Adrenergic beta-Antagonists/pharmacology , Aging/drug effects , Drosophila/growth & development , Energy Metabolism , Longevity/drug effects , Receptors, Adrenergic, beta/drug effects , Animals , Drosophila/drug effects , Male , Mice , Receptors, Adrenergic, beta/metabolism
18.
PLoS One ; 7(6): e39581, 2012.
Article in English | MEDLINE | ID: mdl-22737247

ABSTRACT

Statins such as simvastatin are 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors and standard therapy for the prevention and treatment of cardiovascular diseases in mammals. Here we show that simvastatin significantly increased the mean and maximum lifespan of Drosophila melanogaster (Drosophila) and enhanced cardiac function in aging flies by significantly reducing heart arrhythmias and increasing the contraction proportion of the contraction/relaxation cycle. These results appeared independent of internal changes in ubiquinone or juvenile hormone levels. Rather, they appeared to involve decreased protein prenylation. Simvastatin decreased the membrane association (prenylation) of specific small Ras GTPases in mice. Both farnesyl (L744832) and type 1 geranylgeranyl transferase (GGTI-298) inhibitors increased Drosophila lifespan. These data are the most direct evidence to date that decreased protein prenylation can increase cardiac health and lifespan in any metazoan species, and may explain the pleiotropic (non-cholesterol related) health effects of statins.


Subject(s)
Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Aging/drug effects , Animals , Behavior, Animal , Benzamides/pharmacology , Cardiovascular Diseases/drug therapy , Drosophila melanogaster , Feeding Behavior , Heart/drug effects , Longevity , Male , Methionine/analogs & derivatives , Methionine/pharmacology , Mice , Simvastatin/pharmacology , Ubiquinone/analogs & derivatives , Ubiquinone/pharmacology
19.
PLoS One ; 7(2): e29782, 2012.
Article in English | MEDLINE | ID: mdl-22363408

ABSTRACT

Protein kinase signaling cascades control most aspects of cellular function. The ATP binding domains of signaling protein kinases are the targets of most available inhibitors. These domains are highly conserved from mammals to flies. Herein we describe screening of a library of small molecule inhibitors of protein kinases for their ability to increase Drosophila lifespan. We developed an assay system which allowed screening using the small amounts of materials normally present in commercial chemical libraries. The studies identified 17 inhibitors, the majority of which targeted tyrosine kinases associated with the epidermal growth factor receptor (EGFR), platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) receptors, G-protein coupled receptor (GPCR), Janus kinase (JAK)/signal transducer and activator of transcription (STAT), the insulin and insulin-like growth factor (IGFI) receptors. Comparison of the protein kinase signaling effects of the inhibitors in vitro defined a consensus intracellular signaling profile which included decreased signaling by p38MAPK (p38), c-Jun N-terminal kinase (JNK) and protein kinase C (PKC). If confirmed, many of these kinases will be novel additions to the signaling cascades known to regulate metazoan longevity.


Subject(s)
Drosophila melanogaster/drug effects , Drosophila melanogaster/enzymology , Longevity/drug effects , Protein Kinases/metabolism , Signal Transduction/drug effects , Small Molecule Libraries/analysis , Small Molecule Libraries/pharmacology , Animals , Caloric Restriction , Cells, Cultured , Intracellular Space/drug effects , Intracellular Space/metabolism , MAP Kinase Signaling System/drug effects , Phosphorylation/drug effects , Protein Kinase Inhibitors/analysis , Protein Kinase Inhibitors/pharmacology
20.
Physiol Genomics ; 44(6): 331-44, 2012 Mar 19.
Article in English | MEDLINE | ID: mdl-22274562

ABSTRACT

Sarcopenia is an age-associated loss of skeletal muscle mass and strength that increases the risk of disability. Calorie restriction (CR), the consumption of fewer calories while maintaining adequate nutrition, mitigates sarcopenia and many other age-related diseases. To identify potential mechanisms by which CR preserves skeletal muscle integrity during aging, we used mRNA-Seq for deep characterization of gene regulation and mRNA abundance in skeletal muscle of old mice compared with old mice subjected to CR. mRNA-Seq revealed complex CR-associated changes in expression of mRNA isoforms, many of which occur without a change in total message abundance and thus would not be detected by methods other than mRNA-Seq. Functional annotation of differentially expressed genes reveals CR-associated upregulation of pathways involved in energy metabolism and lipid biosynthesis, and downregulation of pathways mediating protein breakdown and oxidative stress, consistent with earlier microarray-based studies. CR-associated changes not noted in previous studies involved downregulation of genes controlling actin cytoskeletal structures and muscle development. These CR-associated changes reflect generally healthier muscle, consistent with CR's mitigation of sarcopenia. mRNA-Seq generates a rich picture of the changes in gene expression associated with CR, and may facilitate identification of genes that are primary mediators of CR's effects.


Subject(s)
Aging/physiology , Caloric Restriction , Gene Expression Regulation/physiology , Muscle, Skeletal/physiology , RNA, Messenger/metabolism , Sarcopenia/prevention & control , Transcriptome/physiology , Animals , Base Sequence , Biosynthetic Pathways/genetics , Biosynthetic Pathways/physiology , Blotting, Western , Energy Metabolism/genetics , Energy Metabolism/physiology , Gene Library , Male , Mice , Molecular Sequence Data , Muscle, Skeletal/metabolism , Oxidative Stress/physiology , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Sequence Alignment , Sequence Analysis, DNA
SELECTION OF CITATIONS
SEARCH DETAIL
...